B-SOFT Co.,Ltd. (SHE:300451)
5.48
-0.09 (-1.62%)
Feb 13, 2026, 3:04 PM CST
B-SOFT Market Cap
B-SOFT has a market cap or net worth of 8.46 billion as of February 13, 2026. Its market cap has increased by 34.31% in one year.
Market Cap
8.46B
Enterprise Value
7.82B
Revenue
1.12B
Ranking
n/a
PE Ratio
n/a
Stock Price
5.48
Market Cap Chart
Since May 14, 2015, B-SOFT's market cap has increased from 1.37B to 8.46B, an increase of 516.46%. That is a compound annual growth rate of 18.41%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Feb 13, 2026 | 8.46B | 13.22% |
| Dec 31, 2025 | 7.48B | 8.04% |
| Dec 31, 2024 | 6.92B | -31.60% |
| Dec 29, 2023 | 10.12B | -17.04% |
| Dec 30, 2022 | 12.19B | -29.16% |
| Dec 31, 2021 | 17.21B | 7.45% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Jiangsu Hengrui Pharmaceuticals Co.,Ltd | 390.87B |
| WuXi AppTec | 303.15B |
| Shenzhen Mindray Bio-Medical Electronics | 230.22B |
| Sichuan Biokin Pharmaceutical | 120.56B |
| Tianjin Ringpu Bio-Technology | 8.73B |
| Shanghai InnoStar Bio-tech | 8.73B |
| Jiangxi Fushine Pharmaceutical | 8.66B |
| Guilin Sanjin Pharmaceutical | 8.64B |